Friday, August 10, 2012

Dementia research shows practical implications


Caregivers, and healthcare professionals, here is some great information


Here is a great dementia resource for caregivers and healthcare professinals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

Riverland

Researchers have been able to train people with dementia to remember things.
What's been found has got practical implications for anyone (me included) who has ever grumbled through the house looking for the wallet or car keys.
But more so for people with dementia and their families because it's reduced the frustration that can come for both sufferers and carers.
The research also found we're often not aware that we're losing our memory (and our families don't recognise it either). ABC Riverland Today, spoke with Dr Chris Materne, Flinders Research Associate

Wednesday, August 8, 2012

Epilepsy drug reverses memory loss


Caregivers, and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professinals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

ScienceDaily  — Scientists at the Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer's-related impairments in an animal model of the disease

Scientists in the laboratory of Lennart Mucke, MD, who directs neurological research at Gladstone, conducted the research on mice genetically modified to simulate key aspects of Alzheimer's disease. In the study, they show how levetiracetam -- a drug commonly prescribed for patients who suffer from epilepsy -- suppresses abnormal brain activity and restores memory function in these mice. They are publishing their findings online August 6 in the Proceedings of the National Academy of Sciences.
The news comes at a critical time of renewed focus on this most prevalent of neurodegenerative diseases -- and amid a dearth of medications that prevent, halt or reverse the increasingly common condition. Alzheimer's afflicts 5.4 million people in the United States alone -- a figure expected to nearly triple by 2050.
"For the millions of people suffering from Alzheimer's worldwide, we have no effective drug to prevent or reverse memory loss -- the hallmark symptom of this ultimately fatal disease," said Dr. Mucke, who is also a professor of neurology and neuroscience at the University of California, San Francisco (UCSF), with which Gladstone is affiliated. "This study builds on our earlier findings linking Alzheimer's and epilepsy. It provides new insights into the processes underlying memory loss in Alzheimer's and demonstrates the ability of an anti-epileptic drug to block these processes."
Healthy activity in neuronal networks is critical for essential brain functions such as memory. Alzheimer's wreaks havoc on these brain networks, causing disruptions that occasionally escalate into epileptic seizures.
"But whether such neuronal-network disruptions also impair memory was unknown," said Gladstone Postdoctoral Fellow Pascal Sanchez, PhD, who is the paper's lead author. "So we screened seven FDA-approved anti-epileptic medications -- including levetiracetam -- in our Alzheimer's mouse model to see if minimizing these network disruptions could improve memory."
When the Gladstone scientists administered levetiracetam to the mice, they found that abnormal network activity in their brains dropped by 50% in less than a day. After two weeks of treatment, the neurons' ability to communicate with each other improved. The mice also showed better learning and memory in a maze test. Finally, the researchers observed that several proteins that are important for healthy brain function returned to normal levels.
"We are now building on these findings and working to identify the precise mechanism by which this drug reduces brain-network dysfunction and improves memory in our mouse models," said Dr. Sanchez.
The relevance of this discovery to people with Alzheimer's disease is underscored by research that scientists at Johns Hopkins University published just a few months ago. Their study revealed beneficial effects of levetiracetam in a small group of patients with mild cognitive impairment -- a condition that often precedes Alzheimer's. Still, further research is required before the drug is prescribed for Alzheimer's disease.
"Until larger human trials have been completed, we caution against any off-label use of levetiracetam," Dr. Mucke said. "But the consistency between our findings and those just obtained by our colleagues at Johns Hopkins is truly remarkable and, in my opinion, merits additional clinical trials."
Other scientists who participated in this research at Gladstone include Lei Zhu, PhD, Laure Verret, PhD, Keith Vossel, MD, Anna Orr, PhD, Nino Devidze, PhD, Kaitlyn Ho, Gui-Qiu Yu, and Jorge Palop, PhD. John Cirrito, PhD at the Washington University School of Medicine in St. Louis contributed as well. Funding came from a wide variety of sources, including the National Institutes of Health, the National Center for Research Resources, the Alzheimer's Disease Research Center at UCSF and the S.D. Bechtel, Jr. Foundation.
Share this story on Facebook, Twitter, and Google:

Monday, August 6, 2012

Those with dementia may remember when they paint



Caregivers, and healthcare professionals, here is some great information


Here is a great dementia resource for caregivers and healthcare professinals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

Caring.com

Stories of how people with Alzheimer's spark to creative activities involving art, music, and literature are fascinating to hear – and even more so to witness. Better yet, arts activities make life less stressful for dementia caregivers, which is why I can't revisit this topic enough.
  • When my son played guitar for a group of residents in the dementia wing of a nursing home where his grandpa lived for rehab, one woman prone to violence and wandering restlessly planted herself in front of him to happily dance and dance.
  • A friend recently told me her mother, who has advanced Alzheimer's, mostly sits locked into her own silent world, until her daughter plays church hymns on the piano. Then Mom sings every word, clear as a bell.
  • Alzheimer's disease turned actress Rita Hayworth anxious, aggressive, and confused – except when she was painting flowers, a hobby she took up late, and with gusto.
  • A former teacher, new to a long-term dementia care facility, is restless and agitated until he's made the leader of a book group. Passing out books and reading aloud with other residents from large-type books becomes a daily focus and motivation.

Obviously nobody paints or plays music 24/7. And it would be hard for a dementia caregiver to organize artsy activities all day long. But don't be too quick to think it's not for you. You don't have to be a sophisticated arts therapist or spend a lot of energy to reap the benefits:
  1. Arts participation gives someone with dementia a sense of accomplishment and pleasure; the resulting positive emotions reverberate throughout your day.
  2. Finding the right "spark" gives you a go-to activity to help change mood in a pinch, when your loved one is upset or bored.
  3. Going out to, say, a concert or a museum in early- to mid-stage disease gets you both out of the house.
"Alzheimer's doesn't take away memory; your memories are all in there. The part of the brain that's damaged is the part that gives you access to memory. It's as if you put the memories in the glove compartment and you lost the key – and the art unlocked it," says John Zeisel, a sociologist who founded Artz for Alzheimer's, a very cool organization that sets up guided museum tours for people with Alzheimer's, among other programs. Zeisel is also the author of last year's I'm Still Here: A Breakthrough Approach to Understanding Someone Living With Alzheimer's.
Some ideas to get you started:
  • Don't assume the arts have no effect if your loved one was never "artsy." Music and painting reach many people with dementia, even the unlikeliest.
  • Experiment. Some people take to dance, others like to pluck a zither or work in fingerpaint. Rent musicals to watch. Visit a museum every Friday afternoon – it can be the same place, looking at the same art, every week; it's the routine and in-the-moment experience that helps.
  • Keep it simple. My Dad, a lifelong photographer, could no longer operate even the simplest camera, but he never lost his enjoyment of polka music. Paint-by-numbers? Maybe not. Watercolor? Who knew your mom was an Impressionist?
  • It's art therapy, not art class. As you look at paintings or art books, resist the urge to quiz about artists or famous works. Just talk about the colors, shapes, and emotions: "Do you like it? How about this one?"

Saturday, August 4, 2012

Prayer may help stave off Alzheimer's disease


Caregivers, and healthcare professionals, here is some great information


Here is a great dementia resource for caregivers and healthcare professinals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition




Deseret News

Our take: A study, funded by the U.S. National Institutes of Health has found that a habit of regular prayer can reduce the risk of developing Alzheimer's disease by almost half. Researchers found that women, who are at a much higher risk of developing the disease than men, can possibly hold it off through prayer. People with a higher level of spiritual well-being had a slower progression of the disease, according to the research findings.
The next time youre passing a church, a mosque or a synagogue, you might want to pop in for a few moments. A new American-Israeli study has found that praying regularly can reduce the risk of developing Alzheimers disease by 50 percent.
The study, which was funded by the National Institutes of Health in Washington, D.C., found that women, who have a significantly larger chance of developing forms of dementia of which Alzheimers is one form -- could stave off the disease through prayer. The findings confirm earlier studies that indicated religion can play a positive role.
We found that people with higher levels of spiritual well-being had a significantly slower progression of Alzheimers disease, Yakir Kaufman, the head of the neuropsychiatric department at Herzog hospital in Jerusalem, told The Media Line.
Read more about prayer and Alzheimer's on The Media Line.


Thursday, August 2, 2012

Daytime naps linked to dementia

TCaregivers, and healthcare professionals, here is some great information


Here is a great dementia resource for caregivers and healthcare professinals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

elegraph

Taking frequent daytime naps and sleeping too long at night could be early warning signs of dementia, or even contribute to the brain condition, say neurologists.

By , Medical Correspondent
They have found a link between excessive sleep and problems with thinking in the elderly.
Many older people take forty winks, and it is usually only because they need a physical rest from exertion.
But French researchers who looked at results from 5,000 over 65s found the fifth who regularly took long naps scored lower in mental ability tests.
Dr Claudine Berr, from the Institut National de la Santé et de la Recherche Médical (Inserm), told the Alzheimer’s Association International Conference in Vancouver: “These results suggest that excessive daytime sleepiness may be an early predictor of cognitive decline.”
In another study, also presented in Vancouver, American researchers found that routinely sleeping more than nine hours a night, or less than five, was linked to lower mental ability.
Elizabeth Devore from the Brigham and Women’s Hospital in Boston, Massachusetts, looked at 15,000 former nurses over 70.
She and colleagues also found those who slept too much or too little exhibited chemical brain changes indicative of early Alzheimer’s, which is the most common form of dementia.
She said that over time “extreme sleep durations .. may contribute to cognitive decline and early Alzheimer’s”, and not simply be a passive sign of them.
Dr Marie Janson of Alzheimer’s Research UK, said: “There is already some evidence linking sleep duration and disturbances to cardiovascular health and diabetes, so it’s not surprising to see studies examining how sleep might affect cognitive ability over time.
“We can already help people to achieve the recommended seven hours, so regulating sleep could become a strategy to protect against cognitive decline if further evidence bears this out.”


Tuesday, July 31, 2012

Doctors criticize IViG therapy for dementis


Caregivers, and healthcare professionals, here is some great information


Here is a great dementia resource for caregivers and healthcare professinals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

ABC News

Doctors Criticize IViG Study Results

Still, treatment is not advised for patients who have had a major stroke or heart attack, because it can increase the risk of vascular events.
IVIG may not just be a therapy that treats symptoms, according to Dr. Richard Caselli, a neurologist at the Mayo Clinic. The drug seems to block the "destructive process" of inflammation mechanisms in the brain.
"Its strength and therefore importance is that it seems to show a stabilizing effect over a sustained period of time," he said. "Its weakness as the authors state is the small number of patients as well as its unblinded open label format."
But Dr. Normal Foster at the Center for Alzheimer's Care, Imaging and Research at the University of Utah, said the selective reporting of the study's results are "suspicious."
"Not everyone who received treatment was included in the analysis," he said. "The results are intriguing, and I can see why they might want to share them, but they can't be relied upon."
Dr. James E. Galvin, director of the the Pearl Barlow Center for Memory Evaluation and Treatment at New York University's Langone Medical Center, said there may be "technical and logistical limitations" in how many patients might obtain the drug.
Natural Alzheimer's Remedies?Watch Video
Getting Alzheimer's Candidate to Doctor? Watch Video
Welcome to OnCall+ Alzheimer'sWatch Video
But Dr. Sam Gandy, director of Mount Sinai Center for Cognitive Health, said the study, though small, is "still good news, indeed."
He, like other experts, said more studies were needed to prove the drug's promise.
Marder showed no symptoms of the disease in his speech, memory or mood when interviewed by ABCNews.com. He said he first began noticing he was having trouble with his memory a decade ago.
"I thought it was all part of aging," he said.
After a series of tests with a neurologist that were inconclusive, he was preventively put on the drug Aricept. But within a matter of months, an official diagnosis of Alzheimer's disease was made.
"I was devastated," he said. "It blows you away."
As his confusion and forgetfulness worsened, Marder was put on Namenda, as well as Aricept, both of which he has continued for nine years.
Every six months Relkin puts Marder through a series of cognitive tests and so far, the decline has been minimal.
But now, the Marders worry that they may not get the drug if it does not get FDA approval when phase III clinical trials end next year.
And it's expensive – estimated to cost a patient $2,000 to $5,000 every two weeks, including the drug, equipment and a nurse to administer it.
Relkin has told the Marders there were other drugs, but Marder said, "I just want them to keep going."
Marder continues to play tennis and can ride his bike up the 11-mile stretch from Battery Park to the George Washington Bridge -- and back.
"He still has memory issues, no question," said his wife. He tends to repeat himself, but the drug has kept him stable. "There's no doubt he has Alzheimer's, but we would have expected him to progress downward by now."
Luckily, Marder has the self-awareness to know what the drug has done for him.
"It's heaven," he said. "I don't know where I could have been without it.

Sunday, July 29, 2012

IViG therapy shows some success for treating dementia


Caregivers, and healthcare professionals, here is some great information


Here is a great dementia resource for caregivers and healthcare professinals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

ABC News


Jason Marder watched the inevitable decline of his younger brother, who died of Alzheimer's disease at the age of 50. Then, just after his 60th birthday, he too, began to exhibit subtle, early symptoms -- forgetfulness and difficulty focusing on conversations.
At his birthday party, "I noticed he had a hard time keeping track of the presents," said he wife, Karin Marder. "He would forget small things -- like saying he went to the movies when he didn't."
The memory loss progressed, and in 2004, Marder got the dreaded diagnosis: Alzheimer's, a disease that affects 5.1 million Americans.
"It was devastating," said his wife, who works in business apparel. "I thought our lives were going to end."
But today, eight years after his diagnosis, Marder isn't any worse off. He has shown no further memory loss and has remained stable.
The Marders credit intravenous immunoglobulin, or IViG, therapy and a clinical trial that is swirling in controversy this week after an announcement of study results by the Alzheimer's Association International Conference 2012 in Vancouver.
Some doctors hailed the therapy as "exciting," something that could potentially stabilize the disease, while others said the research is inconclusive and the study -- with only 16 subjects -- was too small.
Nonetheless, today Marder, now retired from working in apparel, continues his independent lifestyle, playing tennis and biking in his native New York City.
"Things are going really nicely. I can't complain," said Marder, now 70. "I don't feel any going backwards."
Natural Alzheimer's Remedies?Watch Video
Getting Alzheimer's Candidate to Doctor? Watch Video
Welcome to OnCall+ Alzheimer'sWatch Video
"This drug saved his life," said Karin Marder. "He's independent. He gets on the subways, bikes up and down the Hudson River, gets to go out with friends. He goes to the senior center twice a week. He does creative writing."
For the past five years, Marder has been part of a clinical trial with Dr. Norman R. Relkin, director of the Memory Disorders Program at New York-Presbyterian/Weill Cornell Medical Center.
Relkin presented data that found,overall, that 11 study participants who received the immunotherapy Gammagard (IViG) for three full years showed improvements in cognition, memory, daily functioning and mood.
"We are seeing encouraging results," Relkin told ABCNews.com. And despite negative publicity, "I don't want people to give up hope for symptomatic treatment of the disease".
Intravenous Immunoglobulin is a mixture that contains molecules pooled from plasma, a component of human blood. It is used to treat various autoimmune, infectious and idiopathic diseases, and its supply is therefore limited.
IViG works by using the body's natural defense or immune system and anti-amyloid antibodies. A protein called beta amyloid accumulates in the brain of those who have Alzheimer's.
"We don't know exactly what it targets, but we do know it contains all antibodies that the body produces," said Relkin. "It alters the function of the immune system and decreases inflammation in the brain".
He said that his research team found the rate of brain shrinkage had slowed and the study had "exceeded criteria" to go forward with a phase III trial.
"Typically, untreated Alzheimer's disease shows cognitive decline in three to six months," said Relkin. "Those treated with typical AD drugs show decline in six to nine months. Four out of four patients in the [phase IIB] extension trial were unchanged over a three-year period."
As for Marder, he still has some memory problems, but he can dress himself, cook, clean and walk around the neighborhood.
"I can be away from him for one to two nights," said his wife, Karin.
Every two weeks, a nurse comes to Marder's home and sets up the infusion, which takes about four hours.
"I am happy to spend the time," he said. "Then I walk out of my house and go bike riding."
Besides a minor rash that crops up three to five days after getting the drug, Marder has had no ill side effects with the treatment. "He hasn't even had a cold in five years," said Marder's wife.

Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info